Retrovirus production, retroviral infection, and stable cell line selection

DH Dongqing Huang
SC Shrabanti Chowdhury
HW Hong Wang
SS Sara R. Savage
RI Richard G. Ivey
JK Jacob J. Kennedy
JW Jeffrey R. Whiteaker
CL Chenwei Lin
XH Xiaonan Hou
AO Ann L. Oberg
ML Melissa C. Larson
NE Najmeh Eskandari
DD Davide A. Delisi
SG Saverio Gentile
CH Catherine J. Huntoon
UV Uliana J. Voytovich
ZS Zahra J. Shire
QY Qing Yu
SG Steven P. Gygi
AH Andrew N. Hoofnagle
ZH Zachary T. Herbert
TL Travis D. Lorentzen
AC Anna Calinawan
LK Larry M. Karnitz
SW S. John Weroha
SK Scott H. Kaufmann
BZ Bing Zhang
PW Pei Wang
MB Michael J. Birrer
AP Amanda G. Paulovich
ask Ask a question
Favorite

Retroviral human CPT1A WT and G710E constructs were kindly provided by Taro Hitosugi from Mayo Clinic. These plasmids were pLHCX-hygro- Gateway destination vector-based and were constructed as previously described144. Each of the pLHCX vector plasmid (RV), CPT1A WT (RW), and CPT1A G710E (RM) plasmid was co-transfected with packaging plasmids (EcoPac, pAmphopac, pVSVG) into HEK293T (Sigma-Aldrich) cells using lipofectamine 2000. Retrovirus was harvested 48 h after transfection, filtered w/ 0.45 μm filter, and 8 μg/ml final concentration of polybrene was added. Retroviral infection of the PEO1 WT (A3) and PEO1-CPT1A KO clones (B85), PEO4 WT (C5) and PEO4-CPT1A KO clones (C6) was conducted with freshly harvested retrovirus. Infected cell lines were selected in 25 μg/ml hygromycin for 3 weeks to obtain stable cell lines. Stable expression of the CPT1A WT and G710E mutant protein was verified by western blot of cell lysates as described below.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A